MALARA, GIOVANNA
 Distribuzione geografica
Continente #
NA - Nord America 506
EU - Europa 195
Continente sconosciuto - Info sul continente non disponibili 154
AS - Asia 12
AF - Africa 2
SA - Sud America 1
Totale 870
Nazione #
US - Stati Uniti d'America 401
IT - Italia 141
SE - Svezia 45
CA - Canada 26
SV - El Salvador 15
HN - Honduras 10
GP - Guadalupe 9
GT - Guatemala 9
PR - Porto Rico 9
TT - Trinidad e Tobago 9
NI - Nicaragua 8
CR - Costa Rica 5
CN - Cina 4
CW - ???statistics.table.value.countryCode.CW??? 4
GB - Regno Unito 4
HK - Hong Kong 3
SG - Singapore 3
CH - Svizzera 2
JM - Giamaica 2
SC - Seychelles 2
BB - Barbados 1
BD - Bangladesh 1
BG - Bulgaria 1
BR - Brasile 1
BZ - Belize 1
DE - Germania 1
FR - Francia 1
JP - Giappone 1
LC - Santa Lucia 1
Totale 720
Città #
Ashburn 30
Rome 24
Newark 17
San Jose 13
San Salvador 12
Naples 10
New York 8
Los Angeles 7
Managua 7
Messina 7
Guatemala City 6
Pointe-à-Pitre 6
Santa Clara 6
Atlanta 5
Bemidji 5
Chaguanas 5
Chicago 5
Milan 5
Queens 5
San Francisco 5
San José 5
Tegucigalpa 5
Verona 5
Catania 4
Houston 4
McKinney 4
Modena 4
Montreal 4
North Bergen 4
North Kansas City 4
San Jacinto 4
Willemstad 4
Abbeville 3
Bari 3
Bayamón 3
Brooklyn 3
Charlotte 3
Dallas 3
Florence 3
Janesville 3
Las Vegas 3
Palermo 3
Phoenix 3
Princeton 3
San Antonio 3
Turin 3
Washington 3
Boston 2
Brescia 2
Buffalo 2
Colorado Springs 2
Columbia 2
Eatontown 2
Friday Harbor 2
Genoa 2
Hong Kong 2
Jacksonville 2
Kingston 2
Miami 2
Niagara Falls 2
North York 2
Orlando 2
Philadelphia 2
Richmond 2
San Juan 2
Sunset Beach 2
Tunapuna 2
Vancouver 2
Zurich 2
Afragola 1
Akron 1
Athens 1
Augusta 1
Austin 1
Baltimore 1
Bayonne 1
Beachwood 1
Bear 1
Beijing 1
Belize City 1
Belmar 1
Beloit 1
Bensalem 1
Boise 1
Bologna 1
Bomporto 1
Bridgetown 1
Burlington 1
Burnaby 1
Cagliari 1
Calgary 1
Canning Town 1
Canton 1
Caposele 1
Carteret 1
Cary 1
Cassano d'Adda 1
Castellabate 1
Castries 1
Ceccano 1
Totale 359
Nome #
Guidelines How to Integrate Surgery and Targeted Therapy with Biologics for the Treatment of Hidradenitis Suppurativa: Delphi Consensus Statements from an Italian Expert Panel 22
MANAGEMENT OF PSORIATIC ARTHRITIS: SHOULD THE INTERACTION BETWEEN DERMATOLOGISTS AND RHEUMATOLOGISTS IN CLINICAL PRACTICE BE INTENSIFIED? 19
Improving the disease awareness: how a communication campaign brings hidradenitis suppurativa to the light 19
DERMATITE SEBORROICA: NOSTRA ESPERIENZA CON TERBINAFINA PER VIA ORALE E TOPICA 17
Burden of Disease in Real-Life Setting of Patients With Atopic Dermatitis: Italian Data From the MEASURE-AD Study 16
A consensus-based approach on the management of patients with both psoriasis and psoriatic arthritis in the dermatological and rheumatological settings in Italy: The ADOI PSO-Amore Project 15
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 15
Secukinumab nella psoriasi a placche: dai trials clinici alla real evidence 14
Safe and effective approach of 4 immune-mediated inflammatory diseases with 1 biologic: Our results 14
PSORIASI CONOSCENZA E CURA Un approccio multidisciplinare dalla diagnosi alla terapia. 14
ADALIMUMAB BEYOND APPROVED INDICATIONS: CASE OF THERAPEUTIC SUCCESS AND FUTURE PERSPECTIVES 14
Comparative Outcomes of Kiss Latissimus Dorsi Flap Versus Extended Thoracoabdominal Hatchet Flap for Large Chest Wall Reconstruction: A Retrospective Cohort Study 14
Radiologic evolutions in patients suffering from psoriatic arthritis in treatment with adalimumab over 1 year 13
Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experience 13
Undiagnosed psoriatic arthritis in some patients under ustekinumb treatment for psoriasis: Radiologic evolutions of joints involved in the subsequent diagnosis of psoriatic arthritis 13
Ustekinumab treatment in psoriatic patient suffering from chronic hepatitis C 12
Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study 12
Observation of the behavior of cell-mediated immunity in psoriatic patients treated with ustekinumab: Early results 12
Chronic spontaneous urticaria treated with omalizumab: report of two cases 12
Is apremilast a promising treatment for psoriasis and psoriatic arthritis? 12
Adherence with golimumab treatment in patients with psoriatic arthritis: impact on health-related quality of life and other patient-reported outcomes 12
Nail psoriasis: new therapeutic strategy 12
Effectiveness End Points in Real-World Studies on Biological Therapies in Psoriasis: Systematic Review with Focus on Drug Survival 11
Efalizumab efficacy in the treatment of moderate-severe psoriasis in patients with high cardiovascular risk 11
Sequential treatment of psoriasis with infliximab followed by cyclosporin: Preliminary results of an open-label prospective study 11
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis 11
TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis 11
Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: DIMESKIN-2, a Multicentre Single-Arm Phase IIIb Study 11
An off­‐label adalimumab treatment for hidradenitis suppurativa: a case report 11
A rare skin infection in atopic dermatitis: A case report 11
Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus 10
Terapia fotodinamica e solaraze in associazione nel trattamento delle precancerosi e tumori cutanei non melanoma: risultati preliminari 10
Imaging methyl aminolevulinate-fluorescence of basal cell carcinoma with a new photographic system 9
Assessing the beneficial impact of a patient support program in secukinumab-treated patients with psoriasis in italy 9
A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis 9
Dermatite seborroica e terbinafina: efficacia e tollerabilit{\`a} 9
Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasis 9
Long-term efficacy and safety of apremilast in psoriatic arthritis: Focus on skin manifestations and special populations 9
Pustular psoriasis and Efalizumab: a case report 8
Psoriasis rupioides, an uncommon form of a very common disease: A case report 8
Photodynamic therapy of acne using methyl aminolaevulinate diluted to 4% together with low doses of red light [7] 8
Risankizumab: Daily Practice Experience of High Need Patients 8
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study 8
The psoriatic patient profile for infliximab 8
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations 8
DERMATOFITOSI: CONTRIBUTO CLINICO-EPIDEMIOLOGICO 8
Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis 8
A Novel Smart Treatment For Actinic Keratosis 8
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study – IL PSO (ITALIAN LANDSCAPE PSORIASIS) 8
Una parassitosi insolita alle nostre latitudini 8
HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa 8
Update on the Management of Pediatric Psoriasis: An Italian Consensus 8
La piattaforma online della dermatite atopica dell'adulto: lavori in corso 8
A “local” sporotrichosis: a case report 8
Psoriasi Severa diffusa e mantoux positiva: quale biologico 8
Rapid improvement of nail psoriasis after short term use of ustekinumab administration 8
C-reactive protein and markers for thrombophilia in patients with chronic plaque psoriasis 8
Management of psoriasis and possible complications in patients treated long term with Efalizumab 8
Psoriasis: The Relationship Between Vitamin D3, LL-­‐37, Calcium and Phosphorus Levels 7
Prevalence of alexithymia in patients with psoriasis and its association with disease burden: a multicentre observational study 7
Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis 7
Omalizumab for the treatment of chronic spontaneous urticaria in clinical practice 7
Italian guidelines for therapy of atopic dermatitis—Adapted from consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) 7
BLAISE: considerazioni su di un caso 7
Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study 7
A rare case of non-ketotic hyperglycaemic hemichorea (NHH) in a patient suffering from psoriasis 7
Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study 7
Trattamento con Efalizumab in paziente con psoriasi cronica a placche resistente ad altre terapie 7
An Italian multicentre study on adult atopic dermatitis: persistent versus adult-onset disease 7
Dupilumab Treatment in Children Aged 6–11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study 7
Italian expert consensus for the management of actinic keratosis in immunocompetent patients 7
JCV virus and biologics: some consideration 7
Lymphocutaneous sporotrichosis in an immunocompetent patient: A case report from extreme southern Italy 7
National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis 7
Consensus on the place in therapy of TNF-α inhibitors in the treatment of patients with chronic plaque psoriasis 6
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience 6
Manifestazioni cutanee in 3 pazienti con COVID-19 6
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study 6
Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis 6
Consensus on the management of patients with psoriatic arthritis in a dermatology setting 6
Adalimumab treatment in long-term sufferers of pherocitosis, psoriasis and arthropatic psoriasis 6
Verrucous Nodule of the Finger 6
Secukinumab improves patient perception of anxiety and depression in patients with moderate to severe psoriasis: A post hoc analysis of the supreme study 6
Effectiveness of apremilast in real life in patients with psoriasis: A longitudinal study 6
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis 5
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study 5
Diagnosis and management of moderate to severe atopic dermatitis in adolescents. A Consensus by the Italian Society of Dermatology and Venereology (SIDemaSt), the Italian association of Hospital Dermatologists and Public Health (aDoI), the Italian association of Hospital and territorial allergists and Immunologists (aaIIto), the Italian Society of allergy, asthma and Clinical Immunology (SIaaIC), the Italian Society of Pediatric allergy and Immunology (SIaIP), the Italian Society of allergological, occupational and environmental Dermatology (SIDaPa), and the Italian Society of Pediatric Dermatology (SIDerP) 5
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study 5
HLA-Cw6 allele and efficacy of secukinumab 5
La ciclosporina A nel lichen 5
Thalidomide and discoid lupus erythematosus: case series and review of literature 5
Treatment of psoriasis vulgaris with calcipotriol betamethasone dipropionate combination followed by calcipotriol and assessment of the adjuvant basic use of urea-based emollients 5
Re-induction as a possible alternative modality of dose escalation of infliximab: A prospective evaluation in a small series of psoriatic patients 4
Gender differences in adult atopic dermatitis and clinical implication: Results from a nationwide multicentre study 4
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study 4
Real-world effectiveness and safety of guselkumab for the treatment of psoriasis: A 6-month prospective study in a series of psoriatic patients 4
Tildrakizumab for treatment of moderate to severe psoriasis: an expert opinion of efficacy, safety, and use in special populations 4
Totale 870
Categoria #
all - tutte 6.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.510


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2026/2027870 0 254 249 367 0 0 0 0 0 0 0 0
Totale 870